Expansion● Neutral for Indian equities

From Jab to Pills: Novo Nordisk, Eli Lilly set to take obesity drug battle to India

1 source · first seen 00:25 1 Oct · updated 00:25 1 Oct

The brief

Written from 1 report · check the source before you trade

Novo Nordisk’s oral Wegovy and Eli Lilly’s oral orforglipron are expected to launch in India
New obesity-drug competition may affect Indian pharma firms and healthcare providers

Pick a tag to see all its stories

1 report · earliest 00:25